✦ LIBER ✦

In vivo effects of the anti–interleukin-6 receptor inhibitor tocilizumab on the B cell compartment

✍ Scribed by Petra Roll; Khalid Muhammad; Mathias Schumann; Stefan Kleinert; Hermann Einsele; Thomas Dörner; Hans-Peter Tony

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 229 KB
Volume: 63
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.30242

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of interleukin-6 in a patient with

Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Eliz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

The effects of a COX-2 inhibitor meloxic

The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo

✍ Jun-Feng Liu; Shao-Wei Zhang; Glyn G. Jamieson; Gui-Jun Zhu; Tie-Cheng Wu; Tie-N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 227 KB

## Abstract Our previous study showed that aspirin induced apoptosis of esophageal cancer cells __in vitro__ by inhibiting the pathway of NF‐kappaB downstream regulation of cyclooxygenase‐2. The purpose of this study was to determine if similar changes occurred __in vivo__ in the tumors of patients

In vivo administration of interleukin 1

In vivo administration of interleukin 1 elicits increased Ia antigen expression on B cells through the induction of interleukin 4

✍ Loran M. Killar; Cheryl A. Hatfield; Simon R. Carding; Mary Pan; Gregory E. Wint 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa

In vivo evaluation of the effects of int

In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes

✍ David H. Lynch; Anthony E. Namen; Robert E. Miller 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 892 KB

Contrasting effects of the protein kinas

Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4–6.1 thymoma cell line

✍ Jacques Dornand; Monsif Bouaboula; Arnaud Dupuy D'Angeac; Jean Favero; David Shi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 1017 KB

EL 4-6.1 cells, variants of the murine EL4 thymoma cell line, can be activated by interleukin 1 (IL-I 1 or phorbol 12-myristdte-13-dcetate (PMA), or PMA + IL-I to secrete interleukin 2 (IL-2) and interleukin 4 (IL-4) and to express the IL-2 receptor (IL-2R). To compare the different activation pathw